Nr341 TEST BANK for Pharmacology cje benchmark All topics
fully covered /2026/2027 Latest Update 100% verified - 250
Questions
This exam assesses advanced understanding of pharmacokinetic and pharmacodynamic principles, including
absorption, distribution, metabolism, excretion, receptor theory, dose-response relationships, and therapeutic
drug monitoring. Questions require multi-step reasoning and application to clinical scenarios without reliance on
memorization. It contains 250 multiple-choice questions, each with four distractors and a fully worked rationale
that explains why the keyed answer is correct. Content is organized into 10 focused sections: Pharmacokinetics
and Pharmacodynamics, Autonomic Nervous System Drugs, Cardiovascular and Renal Drugs, Respiratory and
Gastrointestinal Drugs, Central Nervous System Drugs, Endocrine and Metabolic Drugs, Antimicrobial and
Anti-inflammatory Drugs, Cancer and Immunomodulating Drugs, Pain Management and Anesthetics, Drug
Interactions and Adverse Effects. Targeted learning outcomes include: Analyze factors affecting drug absorption,
distribution, and bioavailability.; Interpret and calculate pharmacokinetic parameters (half-life, clearance,
volume of distribution, AUC).; Apply receptor theory and dose-response concepts to predict drug effects and
toxicity.; Evaluate the impact of hepatic and renal impairment on drug dosing.. Every item has been reviewed for
clinical accuracy, current guidelines, and clarity so that students can study with confidence and self-correct as
they work through the bank. Use it as a high-yield review immediately before the exam, or as a structured practice
tool during the unit - the rationales double as concise teaching notes. The recommended writing time is 3 hours,
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-25)
1 A drug with a volume of distribution (Vd) of 500 L and clearance (CL) of 50
L/hr is administered as an intravenous bolus. What is the elimination
half-life (t½)?
A) 5 hours
B) 6.93 hours
C) 10 hours
D) 3.47 hours
Answer: B
Rationale: Half-life is calculated as t½ = 0.693 × Vd / CL = 0.693 × =
6.93 hours. Option A (5 hours) results from using 0.5 instead of 0.693; C (10
hours) from using Vd/CL; D (3.47 hours) from using 0.693 × CL/Vd.
2 A drug follows Michaelis-Menten kinetics with Vmax = 100 mg/hr and Km
= 10 mg/L. At steady state, the drug concentration is 20 mg/L. What is the
rate of drug elimination?
A) 66.7 mg/hr
B) 50 mg/hr
C) 100 mg/hr
D) 33.3 mg/hr
,Answer: A
Rationale: Using Michaelis-Menten equation: rate = (Vmax × C) / (Km + C) =
(100 × 20) / (10 + 20) = 2000/30 = 66.7 mg/hr. Option B (50 mg/hr) is
Vmax/2; C (100 mg/hr) is Vmax; D (33.3 mg/hr) results from using (Vmax ×
Km)/(Km+C).
3 A drug is 90% bound to plasma proteins. If the unbound fraction increases to
20% due to hypoalbuminemia, what is the new apparent volume of
distribution (Vd) relative to the original Vd?
A) 2 times larger
B) 1.8 times larger
C) 1.1 times larger
D) 0.5 times smaller
Answer: A
Rationale: Vd is inversely proportional to the unbound fraction when binding is
primarily to plasma proteins. Original unbound fraction = 10%; new = 20%.
Ratio of Vd new/old = (original unbound)/(new unbound) = 10%/20% = 0.5,
but wait: Vd increases as unbound fraction increases because more drug is free
to distribute. Actually, Vd = Vp + (fu/fut) × Vt, where fu is unbound fraction.
For a drug with low Vd, Vd is proportional to fu. Thus Vd new = Vd old ×
(0.2/0.1) = 2 times larger. Option B (1.8) might be from incorrect binding
calculation; C (1.1) from ignoring tissue binding; D (0.5) from inverting ratio.
4 A drug has an elimination half-life of 8 hours and follows first-order
kinetics. How long will it take for 93.75% of the drug to be eliminated?
A) 32 hours
B) 24 hours
C) 16 hours
D) 40 hours
Answer: A
Rationale: 93.75% eliminated means 6.25% remains. 6.25% = (1/2)^4, so 4
half-lives have passed. 4 × 8 = 32 hours. Option B (24 hours) corresponds to 3
half-lives (87.5% eliminated); C (16 hours) to 2 half-lives (75% eliminated); D
(40 hours) to 5 half-lives (96.875% eliminated).
,5 A drug with a bioavailability of 0.6 and a clearance of 2 L/hr is given orally
every 12 hours. What is the maintenance dose required to achieve an average
steady-state concentration of 5 mg/L?
A) 100 mg
B) 200 mg
C) 50 mg
D) 150 mg
Answer: B
Rationale: Maintenance dose = (Cavg × CL × Ä) / F = (5 mg/L × 2 L/hr × 12 hr)
/ 0.6 = .6 = 200 mg. Option A (100 mg) results from using F=1; C (50
mg) from using =6 hr; D (150 mg) from using CL=1.5 L/hr.
6 A drug follows a one-compartment model with an elimination rate constant
of 0.2 hr¹. If 100 mg is given intravenously, what is the amount of drug in
the body 3 hours after administration?
A) 54.9 mg
B) 60.0 mg
C) 45.1 mg
D) 36.8 mg
Answer: A
Rationale: Amount = Dose × e^(-kt) = 100 × e^(-0.2×3) = 100 × e^(-0.6) "H 100
× 0.549 = 54.9 mg. Option B (60 mg) is using linear decay; C (45.1 mg) uses
e^(-0.8); D (36.8 mg) uses e^(-1.0).
7 A drug has a therapeutic index of 2. If the median effective dose (ED50) is
10 mg, what is the median lethal dose (LD50)?
A) 5 mg
B) 20 mg
C) 10 mg
D) 40 mg
Answer: B
Rationale: Therapeutic index = LD50 / ED50. Given TI=2 and ED50=10 mg,
LD50 = TI × ED50 = 2 × 10 = 20 mg. Option A (5 mg) is ED50/TI; C (10 mg)
is same as ED50; D (40 mg) is ED50 × TI^2.
, 8 A drug is administered as a continuous intravenous infusion at a rate of 50
mg/hr. The clearance is 10 L/hr. What is the steady-state concentration?
A) 5 mg/L
B) 10 mg/L
C) 0.5 mg/L
D) 2 mg/L
Answer: A
Rationale: Steady-state concentration = infusion rate / clearance = 50 mg/hr / 10
L/hr = 5 mg/L. Option B (10 mg/L) is infusion rate × clearance; C (0.5 mg/L)
is clearance/infusion rate; D (2 mg/L) is from using half the infusion rate.
9 A drug has a pKa of 7.4 and is a weak base. In the stomach (pH 1.4), what is
the ratio of ionized to unionized drug?
A) 1:1
B) 10^6:1
C) 1:10^6
D) 10^3:1
Answer: B
Rationale: For a weak base, the Henderson-Hasselbalch equation is pH = pKa +
log([unionized]/[ionized]). Rearranged: [ionized]/[unionized] = 10^(pKa - pH)
= 10^(7.4 - 1.4) = 10^6. Thus ratio ionized:unionized = 10^6:1. Option C is the
inverse; D uses pH-pKa incorrectly.
10 A drug is 95% bound to plasma proteins. If the total plasma concentration
is 100 mg/L, what is the free (unbound) concentration?
A) 5 mg/L
B) 95 mg/L
C) 50 mg/L
D) 10 mg/L
Answer: A
Rationale: Free fraction = 1 - bound fraction = 1 - 0.95 = 0.05. Free
concentration = total concentration × free fraction = 100 × 0.05 = 5 mg/L.
Option B (95 mg/L) is bound concentration; C (50 mg/L) is half; D (10 mg/L)
is 10% of total.
fully covered /2026/2027 Latest Update 100% verified - 250
Questions
This exam assesses advanced understanding of pharmacokinetic and pharmacodynamic principles, including
absorption, distribution, metabolism, excretion, receptor theory, dose-response relationships, and therapeutic
drug monitoring. Questions require multi-step reasoning and application to clinical scenarios without reliance on
memorization. It contains 250 multiple-choice questions, each with four distractors and a fully worked rationale
that explains why the keyed answer is correct. Content is organized into 10 focused sections: Pharmacokinetics
and Pharmacodynamics, Autonomic Nervous System Drugs, Cardiovascular and Renal Drugs, Respiratory and
Gastrointestinal Drugs, Central Nervous System Drugs, Endocrine and Metabolic Drugs, Antimicrobial and
Anti-inflammatory Drugs, Cancer and Immunomodulating Drugs, Pain Management and Anesthetics, Drug
Interactions and Adverse Effects. Targeted learning outcomes include: Analyze factors affecting drug absorption,
distribution, and bioavailability.; Interpret and calculate pharmacokinetic parameters (half-life, clearance,
volume of distribution, AUC).; Apply receptor theory and dose-response concepts to predict drug effects and
toxicity.; Evaluate the impact of hepatic and renal impairment on drug dosing.. Every item has been reviewed for
clinical accuracy, current guidelines, and clarity so that students can study with confidence and self-correct as
they work through the bank. Use it as a high-yield review immediately before the exam, or as a structured practice
tool during the unit - the rationales double as concise teaching notes. The recommended writing time is 3 hours,
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-25)
1 A drug with a volume of distribution (Vd) of 500 L and clearance (CL) of 50
L/hr is administered as an intravenous bolus. What is the elimination
half-life (t½)?
A) 5 hours
B) 6.93 hours
C) 10 hours
D) 3.47 hours
Answer: B
Rationale: Half-life is calculated as t½ = 0.693 × Vd / CL = 0.693 × =
6.93 hours. Option A (5 hours) results from using 0.5 instead of 0.693; C (10
hours) from using Vd/CL; D (3.47 hours) from using 0.693 × CL/Vd.
2 A drug follows Michaelis-Menten kinetics with Vmax = 100 mg/hr and Km
= 10 mg/L. At steady state, the drug concentration is 20 mg/L. What is the
rate of drug elimination?
A) 66.7 mg/hr
B) 50 mg/hr
C) 100 mg/hr
D) 33.3 mg/hr
,Answer: A
Rationale: Using Michaelis-Menten equation: rate = (Vmax × C) / (Km + C) =
(100 × 20) / (10 + 20) = 2000/30 = 66.7 mg/hr. Option B (50 mg/hr) is
Vmax/2; C (100 mg/hr) is Vmax; D (33.3 mg/hr) results from using (Vmax ×
Km)/(Km+C).
3 A drug is 90% bound to plasma proteins. If the unbound fraction increases to
20% due to hypoalbuminemia, what is the new apparent volume of
distribution (Vd) relative to the original Vd?
A) 2 times larger
B) 1.8 times larger
C) 1.1 times larger
D) 0.5 times smaller
Answer: A
Rationale: Vd is inversely proportional to the unbound fraction when binding is
primarily to plasma proteins. Original unbound fraction = 10%; new = 20%.
Ratio of Vd new/old = (original unbound)/(new unbound) = 10%/20% = 0.5,
but wait: Vd increases as unbound fraction increases because more drug is free
to distribute. Actually, Vd = Vp + (fu/fut) × Vt, where fu is unbound fraction.
For a drug with low Vd, Vd is proportional to fu. Thus Vd new = Vd old ×
(0.2/0.1) = 2 times larger. Option B (1.8) might be from incorrect binding
calculation; C (1.1) from ignoring tissue binding; D (0.5) from inverting ratio.
4 A drug has an elimination half-life of 8 hours and follows first-order
kinetics. How long will it take for 93.75% of the drug to be eliminated?
A) 32 hours
B) 24 hours
C) 16 hours
D) 40 hours
Answer: A
Rationale: 93.75% eliminated means 6.25% remains. 6.25% = (1/2)^4, so 4
half-lives have passed. 4 × 8 = 32 hours. Option B (24 hours) corresponds to 3
half-lives (87.5% eliminated); C (16 hours) to 2 half-lives (75% eliminated); D
(40 hours) to 5 half-lives (96.875% eliminated).
,5 A drug with a bioavailability of 0.6 and a clearance of 2 L/hr is given orally
every 12 hours. What is the maintenance dose required to achieve an average
steady-state concentration of 5 mg/L?
A) 100 mg
B) 200 mg
C) 50 mg
D) 150 mg
Answer: B
Rationale: Maintenance dose = (Cavg × CL × Ä) / F = (5 mg/L × 2 L/hr × 12 hr)
/ 0.6 = .6 = 200 mg. Option A (100 mg) results from using F=1; C (50
mg) from using =6 hr; D (150 mg) from using CL=1.5 L/hr.
6 A drug follows a one-compartment model with an elimination rate constant
of 0.2 hr¹. If 100 mg is given intravenously, what is the amount of drug in
the body 3 hours after administration?
A) 54.9 mg
B) 60.0 mg
C) 45.1 mg
D) 36.8 mg
Answer: A
Rationale: Amount = Dose × e^(-kt) = 100 × e^(-0.2×3) = 100 × e^(-0.6) "H 100
× 0.549 = 54.9 mg. Option B (60 mg) is using linear decay; C (45.1 mg) uses
e^(-0.8); D (36.8 mg) uses e^(-1.0).
7 A drug has a therapeutic index of 2. If the median effective dose (ED50) is
10 mg, what is the median lethal dose (LD50)?
A) 5 mg
B) 20 mg
C) 10 mg
D) 40 mg
Answer: B
Rationale: Therapeutic index = LD50 / ED50. Given TI=2 and ED50=10 mg,
LD50 = TI × ED50 = 2 × 10 = 20 mg. Option A (5 mg) is ED50/TI; C (10 mg)
is same as ED50; D (40 mg) is ED50 × TI^2.
, 8 A drug is administered as a continuous intravenous infusion at a rate of 50
mg/hr. The clearance is 10 L/hr. What is the steady-state concentration?
A) 5 mg/L
B) 10 mg/L
C) 0.5 mg/L
D) 2 mg/L
Answer: A
Rationale: Steady-state concentration = infusion rate / clearance = 50 mg/hr / 10
L/hr = 5 mg/L. Option B (10 mg/L) is infusion rate × clearance; C (0.5 mg/L)
is clearance/infusion rate; D (2 mg/L) is from using half the infusion rate.
9 A drug has a pKa of 7.4 and is a weak base. In the stomach (pH 1.4), what is
the ratio of ionized to unionized drug?
A) 1:1
B) 10^6:1
C) 1:10^6
D) 10^3:1
Answer: B
Rationale: For a weak base, the Henderson-Hasselbalch equation is pH = pKa +
log([unionized]/[ionized]). Rearranged: [ionized]/[unionized] = 10^(pKa - pH)
= 10^(7.4 - 1.4) = 10^6. Thus ratio ionized:unionized = 10^6:1. Option C is the
inverse; D uses pH-pKa incorrectly.
10 A drug is 95% bound to plasma proteins. If the total plasma concentration
is 100 mg/L, what is the free (unbound) concentration?
A) 5 mg/L
B) 95 mg/L
C) 50 mg/L
D) 10 mg/L
Answer: A
Rationale: Free fraction = 1 - bound fraction = 1 - 0.95 = 0.05. Free
concentration = total concentration × free fraction = 100 × 0.05 = 5 mg/L.
Option B (95 mg/L) is bound concentration; C (50 mg/L) is half; D (10 mg/L)
is 10% of total.
